The Company has proposed to subscribe 50.49% of the Equity Share Capital of TLL Parenterals Limited (CIN: U21001GJ2023PLC146963). Further details as per SEBI Regulations and Circulars are attached herewith
Trident Lifeline Ltd. Press Release Nov 26 2024
Filed with BSE ·
6ix hasn’t read this filing yet.
Earlier from Trident Lifeline
- Board Meeting Outcome for Outcome Of Board Meeting Held On November 26, 2024
- Outcome Of Board Meeting
Later from Trident Lifeline
- Announcement under Regulation 30 (LODR)-Updates on Acquisition
- Trident Lifeline Ltd. Press Release Dec 02 2024
- Revised Unaudited Financial Results For The Half Year Ended September 30, 2024.
- Trident Lifeline Ltd. Press Release Dec 20 2024
- Board Meeting Outcome for Outcome Of Board Meeting Held On December 23, 2024
Follow Trident Lifeline into a list and get an email when it puts out news.
Follow Trident Lifeline